Evidence map›Paper›PMID 34201159›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Prognostic Value of the Time-to-Positivity in Blood Cultures from Septic Shock Patients with Bacteremia Receiving Protocol-Driven Resuscitation Bundle Therapy: A Retrospective Cohort Study.

Hong-Jun Bae, June-Sung Kim, Muyeol Kim, Youn-Jung Kim, Won Young Kim

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Diagnostic and prognostic value of time to positivity in blood cultures. An opinion paper.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
  3. The Prognostic Value of Time to Positivity ofJournal of acute medicine · 2023
    Article
  4. Serum Thrombomodulin Level Can Predict Mortality in Patients With Sepsis?Medical archives (Sarajevo, Bosnia and Herzegovina) · 2023
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hong-Jun BaeAsan Medical Center, Department of Emergency Medicine, College of Medicine, University of Ulsan, Seoul 05505, Korea.ORCID 0000-0002-9242-1368
June-Sung KimAsan Medical Center, Department of Emergency Medicine, College of Medicine, University of Ulsan, Seoul 05505, Korea.
Muyeol KimAsan Medical Center, Department of Emergency Medicine, College of Medicine, University of Ulsan, Seoul 05505, Korea.
Youn-Jung KimAsan Medical Center, Department of Emergency Medicine, College of Medicine, University of Ulsan, Seoul 05505, Korea.
Won Young KimAsan Medical Center, Department of Emergency Medicine, College of Medicine, University of Ulsan, Seoul 05505, Korea.ORCID 0000-0002-6904-5966
Asan Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo evaluate the prognostic value of the time-to-positivity in patients with culture-positive septic shock.

methodsRetrospective study using a prospective data registry was performed at the emergency department of a tertiary hospital. Consecutive adult patients with septic shock (N = 2499) were enrolled between 2014 and 2018. Bacteremia was defined using blood cultures, and viral and fungal pathogens were excluded. The primary outcome was the 28-day mortality.

resultsIn 803 (46.7%) septic shock patients with bacteremia, median TTP was 10.1 h. The most prevalent isolated bacterial pathogens were

conclusionsThe prognostic value of the TTP in septic shock patients receiving bundle therapy may be limited and its clinical interpretation should only be made on a pathogen-specific basis.

Indexed as

bacteremiamortalitysepsisseptic shocktime-to-positivity

Identifiers

PMID34201159
PMCPMC8228862
OpenAlexW3171274495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.